Bilcare Ltd.
Snapshot View

98.10 -3.75 ▼-3.7%

30 July 2021, 04:00:00 P.M.
Volume: 59,350

Overview View Details

Sector Plastic Products Compare with Sector peers
Industry Plastic Products Compare with Industry peers
Website http://www.bilcare.com
Financial Indicators
Market Cap 230.74 Cr.
Earnings per share (EPS) -8.95 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 44.26 Trailing Twelve Months Ending 2021-03
Book Value / Share 36.66 Trailing Twelve Months Ending 2021-03
Price to Book Value 2.67 Calculated using Price: 98.00
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 2.35 Cr. 23,545,231 Shares
FaceValue 10
Company Profile

Bilcare, incorporated in the year 1987, is engaged in manufacturing pharmaceutical packaging. It has an experience of working with 500 pharma manufacturing companies worldwide.Bilcare is a global leader and an innovation-led packaging solutions provider that partners with the pharmaceutical industry to improve patient healthcare outcomes. The company endeavor to deliver effective and affordable solutions that enhance the speed and quality of drug discovery and help build and protect brands by ensuring the delivery of genuine medicines to patients.

Bilcare PPI offers Innovative Pharmaceutical Packaging Solutions comprising of a wide range of specialty Polymer Films and Aluminum Foils mainly used for packaging of solid dosage pharmaceutical products.

Bilcare GCS provides Global Clinical Material Supplies for new drug discovery projects.

Bilcare Technologies provides Anti-counterfeit (ncID - nonclonableID) solutions for product & people ID authentication and security
The company develops design keeping various aspects into consideration such as end-user, optimum material, composite dosages, on-pack communication, cost-effective, regulatory requirements, etc.It also offers pharmaceutical research and clinical services.

It has representative offices located in Argentina, Bangladesh, Chile, Colombia, Czech Republic, Egypt, France, Indonesia, Iran, Israel, Italy, Jordan, South Korea, Malaysia, Mexico, Pakistan, Saudi Arabia, South Africa, Spain, Taiwan, Thailand, Turkey, Venezuela and Vietnam.

It maintains quality standards prescribed by various agency such USFDA, DEA, IQA, SAP, ISO 9001 and 14001.Bilcare has a global customer base and customers comprise many of the largest global pharmaceutical companies viz. Bristol-Myers Squibb, Dr. Reddy’s, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Ranbaxy, Sanofi-Aventis, Teva to name a few. Bilcare has a strong customer base of over 2,500 customers in over 50 countries worldwide.

For packaging purposes the company uses material like blister films range, aluminium foils, cold formed blisters, wrap systems, closures & containers, flexibles and eco-friendly paper composites.

Bilcare Singapore Pte a wholly owned subsidiary acquired 100 percent stakes in Singapore-based Singular ID. The firm specialises in technology to identify fake drugs.

In 2010 Bilcare won Pharmexcil / Govt of India Patent Award-2009-10.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-3.68%
1 Week
-9.12%
1 Month
+48.75%
3 Month
+86.50%
6 Month
+50.92%
1 Year
+113.03%
2 Year
+409.61%
5 Year
+91.79%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 12.02 4.38 -9.38 -14.86 -9.09 -12.03 -39.29 -274.69 -515.03
Return on Capital Employed (%) 14.35 7.96 3.36 1.16 -1.40 4.40 1.64 -6.38 4.01
Return on Assets (%) 4.06 1.40 -2.83 -4.13 -2.07 -2.26 -5.81 -13.97 -4.82

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 1,335 1,325 1,324 1,096 713 614 400 -70 108
Non Curr. Liab. 1,686 2,050 2,126 2,228 2,090 2,036 960 1,024 535
Curr. Liab. 706 989 866 966 758 745 1,978 2,069 311
Minority Int. 52 54 53 49 59 62 63 64 68
Equity & Liab. 3,779 4,419 4,368 4,340 3,620 3,457 3,402 3,087 1,023
Non Curr. Assets 1,721 2,407 2,444 2,293 2,713 2,669 2,469 2,205 657
Curr. Assets 2,041 2,012 1,924 2,047 907 788 933 882 365
Misc. Exp. not W/O 16
Total Assets 3,779 4,419 4,368 4,340 3,620 3,457 3,402 3,087 1,023

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 3,642 3,547 3,062 2,692 2,603 2,633 2,778 2,997 1,827
Other Income 12 20 18 46 30 39 34 60 97
Total Income 3,654 3,567 3,080 2,738 2,633 2,672 2,813 3,057 1,924
Total Expenditure -3,170 -3,175 -2,823 -2,507 -2,396 -2,445 -2,621 -2,829 -1,782
PBIDT 484 392 257 231 237 227 192 229 142
Interest -165 -167 -217 -236 -151 -176 -249 -283 -174
Depreciation -131 -148 -141 -191 -164 -177 -416 -378 -239
Taxation -48 -19 -23 16 112 -24 8 -21 15
Exceptional Items -117 70 267 157
PAT 140 57 -124 -180 -82 -80 -199 -453 -99

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 92 227 314 -315 177 300 98 206 258
Cash Fr. Inv. -383 -966 -351 247 -358 -129 -203 -104 1,307
Cash Fr. Finan. 285 661 48 119 149 -155 91 -103 -1,600
Net Change -5 -78 12 50 -32 16 -13 -1 -35
Cash & Cash Eqvt 173 94 106 156 73 90 77 76 41

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 30.01 30.01 30.01 30.01 30.01 30.01 30.01 30.01 30.01
Public 69.99 69.99 69.99 69.99 69.99 69.99 69.99 69.99 69.99
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 1.39 1.39 1.39 1.39 1.39 1.39 1.39 1.39 0.00

Announcements View Details

Wed, 21 Jul 2021
Intimation Pursuant To Regulation 23 (9) Of SEBI (Listing Obligations And Disclosures Requirements) (Amendments) Regulations 2018 - Details Of Related Party Transaction
Intimation pursuant to Regulation 23 (9) of SEBI (Listing Obligations and Disclosures Requirements) (Amendments) Regulations 2018 - Details of Related Party Transaction
Wed, 14 Jul 2021
Clarification Sought On Price Movement
Clarification sought on price movement
Wed, 14 Jul 2021
Shareholding for the Period Ended June 30 2021
Bilcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here

Technical Scans View Details

Fri, 30 Jul 2021
Strongly Outperforming Benchmark Index Strongly Outperforming Benchmark Index
Decreasing Relative Strength - Benchmark index Decreasing Relative Strength - Benchmark index
Strongly Outperforming Sectoral Index Strongly Outperforming Sectoral Index
Decreasing Relative Strength - Sectoral index Decreasing Relative Strength - Sectoral index
Both SRS And ARS Above Zero Both SRS And ARS Above Zero

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Astral Ltd. 41,788.82 2,080.00 +0.4%
Supreme Industries Ltd. 26,701.05 2,102.00 +1.2%
Finolex Industries Ltd. 10,970.03 176.80 +0.1%
EPL Ltd. 7,767.65 246.15 +1.6%
Prince Pipes and Fittings Ltd. 7,544.47 685.70 +0.2%
Polyplex Corporation Ltd. 4,730.37 1,506.85 +0.3%
Jindal Poly Films Ltd. 4,402.72 1,005.50 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Astral Ltd. Consolidated 2021-03 103.34 2,080.00 +0.4%
Supreme Industries Ltd. Consolidated 2021-06 24.10 2,102.00 +1.2%
Finolex Industries Ltd. Consolidated 2021-03 14.87 176.80 +0.1%
EPL Ltd. Consolidated 2021-06 30.75 246.15 +1.6%
Prince Pipes and Fittings Ltd. Standalone 2021-03 34.01 685.70 +0.2%
Polyplex Corporation Ltd. Consolidated 2021-03 9.24 1,506.85 +0.3%
Jindal Poly Films Ltd. Consolidated 2021-03 5.57 1,005.50 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Astral Ltd. Consolidated 2021-03 22.06 2,080.00 +0.4%
Supreme Industries Ltd. Consolidated 2021-06 8.11 2,102.00 +1.2%
Finolex Industries Ltd. Consolidated 2021-03 3.49 176.80 +0.1%
EPL Ltd. Consolidated 2021-06 4.45 246.15 +1.6%
Prince Pipes and Fittings Ltd. Standalone 2021-03 7.23 685.70 +0.2%
Polyplex Corporation Ltd. Consolidated 2021-03 1.55 1,506.85 +0.3%
Jindal Poly Films Ltd. Consolidated 2021-03 1.67 1,005.50 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Astral Ltd. Consolidated 2020-03 0.12 2,080.00 +0.4%
Supreme Industries Ltd. Consolidated 2021-03 0.00 2,102.00 +1.2%
Finolex Industries Ltd. Consolidated 2020-03 0.14 176.80 +0.1%
EPL Ltd. Consolidated 2021-03 0.33 246.15 +1.6%
Prince Pipes and Fittings Ltd. Standalone 2020-03 0.31 685.70 +0.2%
Polyplex Corporation Ltd. Consolidated 2020-03 0.25 1,506.85 +0.3%
Jindal Poly Films Ltd. Consolidated 2020-03 0.77 1,005.50 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Astral Ltd. Consolidated 2020-03 18.57 2,080.00 +0.4%
Supreme Industries Ltd. Consolidated 2021-03 30.65 2,102.00 +1.2%
Finolex Industries Ltd. Consolidated 2020-03 13.46 176.80 +0.1%
EPL Ltd. Consolidated 2021-03 15.25 246.15 +1.6%
Prince Pipes and Fittings Ltd. Standalone 2020-03 18.25 685.70 +0.2%
Polyplex Corporation Ltd. Consolidated 2020-03 17.03 1,506.85 +0.3%
Jindal Poly Films Ltd. Consolidated 2020-03 23.77 1,005.50 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Astral Ltd. Consolidated 2020-03 21.43 2,080.00 +0.4%
Supreme Industries Ltd. Consolidated 2021-03 37.26 2,102.00 +1.2%
Finolex Industries Ltd. Consolidated 2020-03 16.38 176.80 +0.1%
EPL Ltd. Consolidated 2021-03 16.92 246.15 +1.6%
Prince Pipes and Fittings Ltd. Standalone 2020-03 20.49 685.70 +0.2%
Polyplex Corporation Ltd. Consolidated 2020-03 17.92 1,506.85 +0.3%
Jindal Poly Films Ltd. Consolidated 2020-03 17.72 1,005.50 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Astral Ltd. Consolidated 2020-03 2,577.90 2,080.00 +0.4%
Supreme Industries Ltd. Consolidated 2021-03 6,357.06 2,102.00 +1.2%
Finolex Industries Ltd. Consolidated 2020-03 2,985.98 176.80 +0.1%
EPL Ltd. Consolidated 2021-03 3,091.60 246.15 +1.6%
Prince Pipes and Fittings Ltd. Standalone 2020-03 1,635.66 685.70 +0.2%
Polyplex Corporation Ltd. Consolidated 2020-03 4,487.10 1,506.85 +0.3%
Jindal Poly Films Ltd. Consolidated 2020-03 3,532.62 1,005.50 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Astral Ltd. Consolidated 2020-03 251.20 2,080.00 +0.4%
Supreme Industries Ltd. Consolidated 2021-03 832.15 2,102.00 +1.2%
Finolex Industries Ltd. Consolidated 2020-03 307.09 176.80 +0.1%
EPL Ltd. Consolidated 2021-03 245.20 246.15 +1.6%
Prince Pipes and Fittings Ltd. Standalone 2020-03 112.51 685.70 +0.2%
Polyplex Corporation Ltd. Consolidated 2020-03 493.82 1,506.85 +0.3%
Jindal Poly Films Ltd. Consolidated 2020-03 488.64 1,005.50 +0.8%